Next Article in Journal
Hypothesized Mechanisms Through Which Exercise May Attenuate Memory Interference
Previous Article in Journal
Hemocompatibility-related Adverse Events Following HeartMate II Left Ventricular Assist Device Implantation between Japan and United States
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Medicina
Volume 56
Issue 3
10.3390/medicina56030128
medicina-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

GSTP1 rs1138272 Polymorphism Affects Prostate Cancer Risk

by
Veljko Santric
1,4,
Milica Djokic
2,
Sonja Suvakov
3,4,
Marija Pljesa-Ercegovac
3,4,
Marina Nikitovic
2,4,
Tanja Radic
3,4,
Miodrag Acimovic
1,4,
Vesna Stankovic
2,
Uros Bumbasirevic
1,4,
Bogomir Milojevic
1,4,
Uros Babic
1,4,
Zoran Dzamic
1,4,
Tatjana Simic
3,4,5,
Dejan Dragicevic
1,4,*,† and
Ana Savic-Radojevic
3,4,*,†
1
Clinic of Urology, Clinical Center of Serbia, 11000 Belgrade, Serbia
2
Institute for Oncology and Radiology of Serbia, 11000 Belgrade, Serbia
3
Institute of Medical and Clinical Biochemistry, 11000 Belgrade, Serbia
4
Faculty of Medicine, University of Belgrade, 11000 Belgrade, Serbia
5
Serbian Academy of Sciences and Arts, 11000 Belgrade, Serbia
*
Authors to whom correspondence should be addressed.
†
co-corresponding author.
Medicina 2020, 56(3), 128; https://doi.org/10.3390/medicina56030128
Submission received: 10 February 2020 / Revised: 28 February 2020 / Accepted: 9 March 2020 / Published: 13 March 2020
Versions Notes

Abstract

Background and Objectives: One of the most frequent genetic alterations reported to date in prostate cancer (PC) is aberrant methylation of glutathione transferase P1 (GSTP1). Taking into consideration the involvement of oxidative stress in PC pathogenesis and recent advances in scientific understanding of the role of GSTP1*Ala114Val rs1138272 polymorphism in carcinogenesis, we hypothesized that this single-nucleotide polymorphism (SNP) influences the risk of PC independently of, or in combination with, other GST polymorphisms, including GSTP1*IIe105Val rs1695 or GSTM1 and GSTT1 deletion polymorphisms. Materials and Methods: Genotyping was performed in 237 PC cases and in 236 age-matched controls by multiplex polymerase chain reaction (PCR) for deletion of GST polymorphisms and by quantitative PCR for SNPs. Results: We found that carriers of either GSTP1*Val (rs1138272) or GSTP1*Val (rs1695) variant alleles had a PC risk compared to individuals with both referent alleles (OR = 4.93, 95%CI: 2.89–8.40, p < 0.001 and OR = 1.8, 95%CI: 1.19–2.73, p = 0.006, respectively). Additionally, in a haplotype analysis we found that individuals with GSTP1*C haplotype, represented by both variant alleles (GSTP1*Val rs1695 + GSTP1*Val rs1138272), had a 5.46 times higher risk of PC development compared to individuals with the most frequent haplotype (95%CI = 2.56–11.65, p < 0.001), suggesting a potential role of those variants in PC susceptibility. A regression analysis on the number of risk-associated alleles per individual (GSTM1*active, GSTT1*null, GSTP1*Val rs1695 and GSTP1*Val rs1138272) showed a significant increase in the risk of developing PC, from 3.65-fold in carriers of two risk alleles (95%CI = 1.55–8.61, p = 0.003) to an approximately 12-fold increase in carriers of all four risk alleles (95%CI = 3.05–44.93, p < 0.001). Conclusion: Prostate cancer may be influenced by multiple glutathione transferase (GST) polymorphic genes, especially GSTP1, highlighting the role of gene–gene interactions in human susceptibility to this cancer.
Keywords: GSTP1; polymorphism; prostate cancer; risk; haplotype GSTP1; polymorphism; prostate cancer; risk; haplotype

Share and Cite

MDPI and ACS Style

Santric, V.; Djokic, M.; Suvakov, S.; Pljesa-Ercegovac, M.; Nikitovic, M.; Radic, T.; Acimovic, M.; Stankovic, V.; Bumbasirevic, U.; Milojevic, B.; et al. GSTP1 rs1138272 Polymorphism Affects Prostate Cancer Risk. Medicina 2020, 56, 128. https://doi.org/10.3390/medicina56030128

AMA Style

Santric V, Djokic M, Suvakov S, Pljesa-Ercegovac M, Nikitovic M, Radic T, Acimovic M, Stankovic V, Bumbasirevic U, Milojevic B, et al. GSTP1 rs1138272 Polymorphism Affects Prostate Cancer Risk. Medicina. 2020; 56(3):128. https://doi.org/10.3390/medicina56030128

Chicago/Turabian Style

Santric, Veljko, Milica Djokic, Sonja Suvakov, Marija Pljesa-Ercegovac, Marina Nikitovic, Tanja Radic, Miodrag Acimovic, Vesna Stankovic, Uros Bumbasirevic, Bogomir Milojevic, and et al. 2020. "GSTP1 rs1138272 Polymorphism Affects Prostate Cancer Risk" Medicina 56, no. 3: 128. https://doi.org/10.3390/medicina56030128

APA Style

Santric, V., Djokic, M., Suvakov, S., Pljesa-Ercegovac, M., Nikitovic, M., Radic, T., Acimovic, M., Stankovic, V., Bumbasirevic, U., Milojevic, B., Babic, U., Dzamic, Z., Simic, T., Dragicevic, D., & Savic-Radojevic, A. (2020). GSTP1 rs1138272 Polymorphism Affects Prostate Cancer Risk. Medicina, 56(3), 128. https://doi.org/10.3390/medicina56030128

Article Metrics

Back to TopTop